Torrent Pharmaceuticals Ltd.
Fundamentals
- Market cap
- ₹1.53 lakh cr
- P/E
- 70.65×
- ROE
- 25.79%
- Debt / equity
- 1.76
- Div yield
- 0.84%
- 52-week range
- 3165.00 — 4712.90
Company snapshot
Torrent Pharmaceuticals Ltd.
Pharmaceuticals
₹1.57 L cr
P/E 72.61×
Latest quarter · Mar 2026
Sales₹4,197 cr
Net profit₹364 cr
Op. margin+32.3%
EPS₹11.49
Strength & growth
Debt / equity1.76×
Current ratio1.13×
Sales CAGR+7.7%
EPS CAGR+2.1%
The timeline — 5 notes on Torrent Pharmaceuticals Ltd.
May 2026
- 27 May 26 · 5:54 PM IST Brief Brief · Earnings · Mega cap
Torrent Pharmaceuticals files transcript for May earnings call
The company released the formal record of its post-results conference call. It contains no new information beyond the live discussion on May 22, 2026.
- 22 May 26 · 6:40 PM IST Brief Brief · Concalls · Mega cap
Torrent Pharma walks back US growth targets to single digits
Management abandons its $200 million annual revenue goal, citing a slower two-year outlook for the US market.
- 22 May 26 · 5:02 PM IST Brief Brief · Earnings · Mega cap
Torrent Pharmaceuticals FY26 results confirm revenue growth of 21%
The company formally posted audited annual figures and a ₹5,000 cr QIP resolution, both of which were flagged in mid-May.
- 22 May 26 · 4:57 PM IST Brief Brief · Earnings · Mega cap
Torrent Pharmaceuticals eyes ₹5,000 cr QIP following JB Pharma buy
Revenue hit ₹4,197 crore on maiden JB Pharma consolidation; board recommends ₹9 dividend despite profit hit from acquisition costs.
- 22 May 26 · 4:53 PM IST Brief Brief · Earnings · Mega cap
Torrent's India sales grew 43% in Q4, beating the US for the first time
The domestic business outpaced the international segment, a shift that reshapes where the pharmaceutical giant's earnings come from.